On Monday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was -5.19% drop from the session before settling in for the closing price of $36.45. A 52-week range for SWTX has been $19.61 – $53.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. When this article was written, the company’s average yearly earnings per share was at 39.40%. With a float of $65.79 million, this company’s outstanding shares have now reached $73.49 million.
Let’s determine the extent of company efficiency that accounts for 305 employees. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.
SpringWorks Therapeutics Inc (SWTX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 11.56%, while institutional ownership is 101.78%. The most recent insider transaction that took place on Sep 03 ’24, was worth 1,988,033. In this transaction Chief Executive Officer of this company sold 49,000 shares at a rate of $40.57, taking the stock ownership to the 1,063,368 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Chief Operating Officer sold 20,000 for $40.65, making the entire transaction worth $812,954. This insider now owns 229,600 shares in total.
SpringWorks Therapeutics Inc (SWTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 39.40% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Looking closely at SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days average volume was 2.78 million, which is a jump from its year-to-date volume of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 82.01%. Additionally, its Average True Range was 1.90.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 41.15%, which indicates a significant decrease from 62.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.98% in the past 14 days, which was lower than the 44.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.61, while its 200-day Moving Average is $40.12. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $36.18. Second resistance stands at $37.81. The third major resistance level sits at $38.63. If the price goes on to break the first support level at $33.73, it is likely to go to the next support level at $32.91. Now, if the price goes above the second support level, the third support stands at $31.28.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 74,386K outstanding shares of the company, which has a market capitalization of 2.56 billion. As of now, sales total 5,450 K while income totals -325,100 K. Its latest quarter income was 59,730 K while its last quarter net income were -39,920 K.
